Compare trial results at 24 months of two different minimally invasive glaucoma surgeries— the Hydrus™ and the iStent® without cataract surgery being performed at the same time.
The eyeWatch™ is an experimental Adjustable Glaucoma Drainage Device developed by the Swiss company Rheon Medical. In theory, it allows adjustment of IOP after implantation.
The InnFocus MicroShunt® may very well be what we were hoping the EX-PRESS® Glaucoma Filtration Device would be: a faster, safer alternative to trabeculectomy.
Trabecular bypass implants are tubes that work by shunting aqueous fluid from the anterior chamber through the sclera into the subconjunctival space.
